Molecular genetics of renal cell carcinoma

Cancer Genetics and Cytogenetics

Volumn 104, Issue 1, 1998, Pages 1-18

  Erlandsson, R ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLAMINO ACID RELEASING ENZYME; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

BREAST CANCER; CHROMOSOME 3P; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CHROMOSOME MAP; COLON POLYPOSIS; COLORECTAL CARCINOMA; GENE EXPRESSION; GENE LOCATION; HETEROZYGOSITY LOSS; HUMAN; KIDNEY CARCINOMA; MOLECULAR GENETICS; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0032126623     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00384-1     Document Type: Article

References (190)

1. M.J. Bishop The molecular genetics of cancer Science 235 1987 305 311
2. A.J. Cohen F.P. Li S. Berg D.J. Marchetto S. Tsai S.C. Jacobs R.S. Brown Hereditary renal-cell carcinoma associated with a chromosomal translocation N Engl J Med 301 1979 592 595
3. N. Wang K.L. Perkins Involvement of band 3p14 in t(3;8) hereditary renal carcinoma Cancer Genet Cytogenet 11 1984 479 481
4. M.A. Yoshida K. Ohyashiki H. Ochi Z. Gibas J.E. Pontes G.R.J. Prout R. Huben A.A. Sandberg Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma Cancer Res 46 1986 2139 2147
5. P.R. Carroll V.V.S. Murty V. Reuter S. Jhanwar W.R. Fair W.F. Whitmore R.S.K. Chaganti Abnormalities at chromosome region 3p12–14 characterize clear cell renal carcinoma Cancer Genet Cytogenet 26 1987 253 259
6. G. Kovacs S. Szucs W. De Riese H. Baumgartel Specific chromosome aberration in human renal cell carcinoma Int J Cancer 40 1987 171 178
7. G. Kovacs R. Erlandsson F. Boldog S. Ingvarsson R. Müller-Brechlin G. Klein J. Sümegi Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma Proc Natl Acad Sci USA 85 1988 1571 1575
8. Mitelman F (1995): Catalog of Chromosome Aberrations in Cancer. ed. 5, Wiley-Liss, New York.
9. F.P. Li H.J. Decker B. Zbar V.P. Stanton Jr G. Kovacs B.R. Seizinger H. Aburatani A.A. Sandberg S. Berg S. Hosoe R.S. Brown Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation genetics of familial renal carcinoma Ann Intern Med 118 1993 106 111
10. G. Kovacs P. Brusa W. De Riese Tissue-specific expression of a constitutional 3;6 translocation development of multiple bilateral renal-cell carcinomas Int J Cancer 43 1989 422 427
11. G. Kovacs E. Hoene Loss of der(3) in renal carcinoma cells of a patient with constitutional t(3;12) Hum Genet 78 1988 148 150
12. T.A. Walter C.S. Berger A.A. Sandberg The cytogenetics of renal tumors where do we stand, where do we go? Cancer Genet Cytogenet 43 1989 15 34
13. J. Limon K. Mrozek S. Heim P. Elfving B. Nedoszytko M. Babinska N. Mandahl R. Lundgren F. Mitelman On the significance of trisomy 7 and sex chromosome loss in renal cell carcinoma Cancer Genet Cytogenet 49 1990 259 263
14. M. Shimizu J. Yokota N. Mori T. Shuin M. Shinoda M. Terada M. Oshimura Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR Oncogene 5 1990 185 194
15. M.A. Yoshida M. Shimizu T. Ikeuchi A. Tonomura J. Yokota M. Oshimura In vitro growth suppression and morphological change in a human renal cell carcinoma cell line by the introduction of normal chromosome 3 via microcell fusion Mol Carcinog 9 1994 114 121
16. Y. Sanchez A. el-Naggar S. Pathak A.M. Killary A tumor suppressor locus within 3p14–p12 mediates rapid cell death of renal cell carcinoma in vivo Proc Natl Acad Sci USA 91 1994 3383 3387
17. B. Zbar H. Brauch C. Talmadge M. Linehan Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma Nature 327 1987 721 724
18. U. Bergerheim M. Nordenskjöld V.P. Collins Deletion mapping in human renal cell carcinoma Cancer Res 49 1989 1390 1396
19. A.H. van der Hout K. Kok A. van den Berg J.W. Oosterhuis B. Carritt C.H.C.M. Buys Direct molecular analysis of a deletion of 3p in tumors from patients with sporadic renal cell carcinoma Cancer Genet Cytogenet 32 1988 281 285
20. A.H. van der Hout P. van der Vlies C. Wijmenga F.P. Li J.W. Oosterhuis C.H. Buys The region of common allelic losses in sporadic renal cell carcinoma is bordered by the loci D3S2 and THRB Genomics 11 1991 537 542
21. T. Shuin K. Kondo S. Torigoe T. Kishida Y. Kubota M. Hosaka Y. Nagashima H. Kitamura F. Latif B. Zbar M.I. Lerman M. Yao Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas Cancer Res 54 1994 2852 2855
22. Z. Zhuang M.J. Roth M.R. Emmert-Buck I.A. Lubensky L.A. Liotta D. Solomon Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction Acta Cytol 38 1994 671 675
23. P. Anglard K. Tory H. Brauch G.H. Weiss F. Latif M.J. Merino M.I. Lerman B. Zbar W.M. Linehan Molecular analysis of genetic changes in the origin and development of renal cell carcinoma Cancer Res 51 1991 1071 1077
24. J.C. Presti Jr P.H. Rao Q. Chen V.E. Reuter F.P. Li W.R. Fair S.C. Jhanwar Histopathological, cytogenetic and molecular characterization of renal cortical tumors Cancer Res 51 1991 1544 1552
25. K. Yamakawa R. Morita E. Takahashi T. Hori J. Ishikawa Y. Nakamura A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma Cancer Res 51 1991 4707 4711
26. J. Lubinski P. Hadaczek J. Podolski A. Toloczko A. Sikorski P. McCue T. Druck K. Huebner Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas Cancer Res 54 1994 3710 3713
27. K. Foster P.A. Crossey P. Cairns J.W. Hetherington F.M. Richards M.H. Jones E. Bentley N.A. Affara M.A. Ferguson-Smith E.R. Maher Molecular genetic investigation of sporadic renal cell carcinoma analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22 Br J Cancer 69 1994 230 234
28. R. Morita J. Ishikawa M. Tsutsumi K. Hikiji Y. Tsukada S. Kamidono S. Maeda Y. Nakamura Allelotype of renal cell carcinoma Cancer Res 51 1991 820 823
29. R. Morita S. Saito J. Ishikawa O. Ogawa O. Yoshida K. Yamakawa Y. Nakamura Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma Cancer Res 51 1991 5817 5820
30. C.A. Thrash-Bingham R.E. Greenberg S. Howard A. Bruzel M. Bremer A. Goll H. Salazar J.J. Freed K.D. Tartof Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes Proc Natl Acad Sci USA 92 1995 2854 2858
31. M.M. Walther J.R. Gnarra L. Elwood H.J. Xu C. Florence P. Anglard S.X. Hu C. King E. Trahan K. Hurley D. Sens D. Venzon S. Liu G.S. Jaffe W.F. Benedict W.M. Linehan Loss of heterozygosity occurs centromeric to RB without associated abnormalities in the retinoblastoma gene in tumors from patients with metastatic renal cell carcinoma J Urol 153 1995 2050 2054
32. T. Uchida C. Wada C. Wang S. Egawa H. Ohtani K. Koshiba Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma Cancer Res 54 1994 3682 3685
33. H. Brauch S. Pomer T. Hieronymus T. Schadt H. Lohrke D. Komitowski Genetic alterations in sporadic renal-cell carcinoma molecular analyses of tumor suppressor gene harboring chromosomal regions 3p, 5q, and 17p World J Urol 12 1994 162 168
34. Y. Suzuki G. Tamura C. Maesawa T. Fujioka T. Kubo R. Satodate Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction Virchows Archiv 424 1994 453 457
35. A.K. el-Naggar J.G. Batsakis G. Wang M.S. Lee PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms Diagn Mol Pathol 2 1993 269 276
36. J.C. Presti Jr V.E. Reuter C. Cordon-Cardo M. Mazumdar W.R. Fair S.C. Jhanwar Allelic deletions in renal tumors histopathological correlations Cancer Res 53 1993 5780 5783
37. R.E. Reiter P. Anglard S. Liu J.R. Gnarra W.M. Linehan Chromosome 17p deletions and p53 mutations in renal cell carcinoma Cancer Res 53 1993 3092 3097
38. T. Uchida C. Wada T. Shitara S. Egawa S. Mashimo K. Koshiba Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma J Urol 150 1993 1298 1301
39. P. Anglard E. Trahan S. Liu F. Latif M.J. Merino M.I. Lerman B. Zbar W.M. Linehan Molecular and cellular characterization of human renal cell carcinoma cell lines Cancer Res 52 1992 348 356
40. A. Kovacs S. Storkel W. Thoenes G. Kovacs Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas J Pathol 167 1992 273 277
41. G. Kovacs M. Kiechle-Schwarz G. Scherer H.F. Kung Molecular analysis of the chromosome 11p region in renal cell carcinomas Cell Mol Biol 38 1992 59 62
42. O. Ogawa T. Habuchi Y. Kakehi M. Koshiba T. Sugiyama O. Yoshida Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p Cancer Res 52 1992 1881 1885
43. O. Ogawa Y. Kakehi K. Ogawa M. Koshiba T. Sugiyama O. Yoshida Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma Cancer Res 51 1991 949 953
44. K. Oka J. Ishikawa J.M. Bruner R. Takahashi H. Saya Detection of loss of heterozygosity in the p53 gene in renal cell carcinoma and bladder cancer using the polymerase chain reaction Mol Carcinog 4 1991 10 13
45. M. Linehan E. Miller P. Anglard M. Merino B. Zbar Improved detection of allele loss in renal cell carcinomas after removal of leukocytes by immunologic selection J Natl Cancer Inst 81 1989 287 290
46. D.B. Rukstalis G.J. Bubley J.P. Donahue J.P. Richie J.G. Seidman W.C. DeWolf Regional loss of chromosome 6 in two urological malignancies Cancer Res 49 1989 5087 5090
47. R. Erlandsson U.S. Bergerheim F. Boldog Z. Marcsek K. Kunimi B.Y. Lin S. Ingvarsson J.S. Castresana W.H. Lee E. Lee G. Klein J. Sümegi A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (Rcc) Oncogene 5 1990 1207 1211
48. R.F. Schwerdtle S. Störkel C. Neuhaus H. Brauch E. Weidt W. Brenner R. Hohenfellner C. Huber H.J. Decker Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p, and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma Cancer Res 56 1996 2927 2930
49. Y. Suzuki G. Tamura C. Maesawa T. Fujioka T. Kubo R. Satodate Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction Virchows Arch 424 1994 453 457
50. G. Kovacs S. Frisch Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas Cancer Res 49 1989 651 659
51. P. Cairns K. Tokino Y. Eby D. Sidransky Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas Cancer Res 55 1995 224 227
52. F.J. Rauscher The WT1 Wilms tumor gene product a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor FASEB J 7 1993 896 903
53. R. Wooster G. Bignell J. Lancaster S. Swift S. Seal J. Mangion N. Collins S. Gregory C. Gumbs G. Mioklem R. Barfoot R. Hamoudi S. Patel C. Rice P. Biggs Y. Hashim A. Smith F. Connor A. Arason J. Gudmundsson D. Ficenec D. Kelsell Identification of the breast cancer susceptibility gene BRCA2 Nature 378 1995 789 792
54. E.R. Fearon R.C. Kathleen J.M. Nigro S.E. Kern J.W. Simons J.M. Ruppert S.R. Hamilton A.C. Preisinger G. Thomas K.W. Kinzler B. Vogelstein Identification of a chromosome 18q gene that is altered in colorectal cancers Science 247 1990 49 56
55. M. Wilhelm U. Krause G. Kovacs Diagnosis and prognosis of renal-cell tumors a molecular approach World J Urol 13 1995 143 148
56. S. Storkel E. van den Berg Morphological classification of renal cancer World J Urol 13 1995 153 158
57. P. Granata P. Portentoso E. Minelli R. Righi E. Meroni A.V. Bono E. Pozzi M. Salvadore P. Simi R. Casalone Clonal chromosome changes in renal carcinoma do not correlate with clinical stages and histopathologic grades Cancer Genet Cytogenet 64 1992 30 34
58. J.M. Hall M.K. Lee B. Newman J.E. Morrow L.A. Anderson B. Huey M.-C. King Linkage of early-onset familial breast cancer to chromosome 17q21 Science 250 1990 1684 1689
59. K.R. Cho J.D. Oliner J.W. Simons L. Hedrick E.R. Fearon A.C. Preisinger P. Hedge G.A. Silverman B. Vogelstein The DCC gene structural analysis and mutations in colorectal carcinomas Genomics 19 1994 525 531
60. L.A. Aaltonen P. Peltomäki F.S. Leach P. Sistonen L. Pylkkänen J.P. Mecklin H. Järvinen S.M. Powell J. Jen S.R. Hamilton G.M. Petersen K.W. Kinzler B. Vogelstein A. de la Chapelle Clues to the pathogenesis of familial colorectal cancer Science 260 1993 812 816
61. C. Wu Y. Akiyama K. Imai S. Miyake H. Nagasaki M. Oto S. Okabes T. Iwama K. Mitamura H. Masumitsu T. Nomizu S. Baba K. Maruyama Y. Yuasa DNA alteration in cells from hereditary non-polyposis colorectal cancer Oncogene 9 1994 991 994
62. R. Fishel M.K. Lescoe M.R.S. Rao N.G. Copeland N.A. Jenkins J. Garber M. Kane R. Kolodner The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer Cell 75 1993 1027 1038
63. W.M. Linehan M.I. Lerman B. Zbar Identification of the von Hippel-Lindau (Vhl) gene Its role in renal cancer JAMA 273 1995 564 570
64. B.R. Seizinger G.A. Rouleau L.J. Ozelius A.H. Lane G.E. Farmer J.M. Lamiell J. Haines J.W. Yuen D. Collins D. Majoor-Krakauer T. Bonner C. Mathew A. Rubenstein J. Halperin A. McConkie-Rosell J.S. Green J.A. Trofatter B.A. Ponder Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma Nature 332 1988 268 269
65. E.R. Maher E. Bentley J.R. Yates D. Barton A. Jennings I.W. Fellows M.A. Ponder B.A. Ponder C. Benjamin R. Harris M.A. Ferguson-Smith Mapping of von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis J Neurol Sci 100 1990 27 30
66. B.R. Seizinger D.I. Smith M.R. Filling-Katz H. Neumann J.S. Green P.L. Choyke K.M. Anderson R.N. Freiman S.M. Klauck J. Whaley H.J.H. Decker Y.E. Hsia D. Collins J. Halperin J.M. Lamiell B. Oostra M.H. Waziri M.B. Gorin G. Scherer Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease Proc Natl Acad Sci USA 88 1991 2864 2868
67. M.A. Pericak-Vance K.J. Nunes E. Whisenant D.B. Loeb K.W. Small J.M. Stajich J.B. Rimmler L.H. Yamaoka D.I. Smith H.A. Drabkin J.M. Vance Genetic mapping of dinucleotide repeat polymorphisms and von Hippel-Lindau disease on chromosome 3p25–26 J Med Genet 30 1993 487 491
68. P.A. Crossey K. Foster F.M. Richards M.E. Phipps F. Latif K. Tory M.H. Jones E. Bentley R. Kumar M.I. Lerman B. Zbar N.A. Affara M.A. Ferguson-Smith E.R. Maher Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease analysis of allele loss in VHL tumours Hum Genet 93 1994 53 58
69. K. Tory H. Bruach M. Linehan D. Barba E. Oldfield M. Filling-Katz B. Seizinger Y. Nakamura R. White F.F. Marshall M.I. Lerman B. Zbar Specific genetic change in tumors associated with von Hippel-Lindau disease J Natl Cancer Inst 81 1989 1097 1101
70. H.J. Decker R.M. Gemmill H.P. Neumann T.A. Walter A.A. Sandberg Loss of heterozygosity on 3p in a renal cell carcinoma in von Hippel-Lindau syndrome Cancer Genet Cytogenet 39 1989 289 293
71. J.M. Whaley J. Naglich L. Gelbert Y.E. Hsia J.M. Lamiell J.S. Green D. Collins H.P. Neumann J. Laidlaw F.P. Li A.J.P. Klein-Szanto B. Seizinger N. Kley Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma Am J Hum Genet 55 1994 1092 1102
72. D.R. Duan A. Pause W.H. Burgess T. Aso D.Y.T. Chen K.P. Garrett R.C. Conaway J.W. Conaway W.M. Linehan R.D. Klausner Inhibition of transcription elongation by the VHL tumor suppressor protein Science 269 1995 1402 1406
73. A. Kibel O. Iliopoulos J.A. Decaprio W.G. Kaelin Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C Science 269 1995 1444 1446
74. J. Lis C. Wu Protein traffic on the heat shock promoter Parking, stalling and trucking along Cell 74 1993 1 4
75. A. Krumm T. Meulia M. Groudine Common mechanisms for the control of eukaryotic transcriptional elongation Bioessays 15 1995 659 665
76. T. Aso W.S. Lane J.W. Conaway R.C. Conaway Elongin (Siii) A multisubunit regulator of elongation by RNA polymerase II Science 269 1995 1439 1443
77. K.P. Garrett S. Tan J.N. Bradsher W.S. Lane J.W. Conaway R.C. Conaway Molecular cloning of an essential subunit of RNA polymerase II elongations factor SIII Proc Natl Acad Sci USA 91 1994 5237 5241
78. K.P. Garrett T. Aso J.N. Bradsher S.I. Foundling W.S. Lane R.C. Conaway J.W. Conaway Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog Proc Natl Acad Sci USA 92 1995 7172 7176
79. J.R. Gnarra S. Zhou M.J. Merrill J.R. Wagner A. Krumm E. Papavassiliou E.H. Oldfield R.D. Klausner W.M. Linehan Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene Proc Natl Acad Sci USA 93 1996 10589 10594
80. G. Siemeister K. Weindel K. Mohrs B. Barleon G. Martiny-Baron D. Marme Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein Cancer Res 56 1996 2299 2301
81. F. Chen T. Kishida M. Yao T. Hustad D. Glavac M. Dean J.R. Gnarra M.L. Orcutt F.M. Duh G. Glenn J. Green Y.E. Hsia J. Lamiell H. Li M.H. Wei L. Schmidt K. Tory I. Kuzmin T. Stackhouse F. Latif W.M. Linehan M. Lerman B. Zbar Germline mutations in the von Hippel-Lindau disease tumor suppressor gene correlations with phenotype Hum Mutat 5 1995 66 75
82. J.R. Gnarra K. Tory Y. Weng L. Schmidt M.H. Wei H. Li F. Latif S. Liu F. Chen F.M. Duh I. Lubensky D.R. Duan C. Florence R. Pozzatti M.M. Walther N.H. Bander H.B. Grossman H. Brauch S. Pomer J.D. Brooks W.B. Isaacs M.I. Lerman B. Zbar W.M. Linehan Mutations of the VHL tumour suppressor gene in renal carcinoma Nat Genet 7 1994 85 90
83. J.G. Herman F. Latif Y. Weng M.I. Lerman B. Zbar S. Liu D. Samid D.S. Duan J.R. Gnarra W.M. Linehan S.B. Baylin Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma Proc Natl Acad Sci USA 91 1994 9700 9704
84. O. Iliopoulos A. Kibel S. Gray W.G. Kaelin Tumour suppression by the human von Hippel-Lindau gene product Nat Med 1 1995 822 826
85. M.G. Alexandrow H.L. Moses Transforming growth factor β and cell cycle regulation Cancer Res 55 1995 1252 1257
86. S. Mathew V.V. Murty S. Cheifetz D. George J. Massagué R.S. Chaganti Transforming growth factor receptor gene TGFBR2 maps to human chromosome band 3p22 Genomics 20 1994 114 115
87. J. Wang L. Sun L. Myeroff X. Wang L.E. Gentry J. Yang J. Liang E. Zborowska S. Markowitz J.K. Willson M.G. Brattain Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells J Biol Chem 270 1995 22044 22049
88. M.L.-S. Tsang L. Zhou B.-L. Zheng J. Wenker G. Fransen J. Humphrey J.M. Smith M. O’Connor-McCourt R. Lucas J.A. Weatherbee Characterization of recombinant soluble human transforming growth factor-β receptor type II (rhTGF-βsRII) Cytokine 7 1995 389 397
89. R.S. Chari D.T. Price S.R. Sue W.C. Meyers R.L. Jirtle Down-regulation of transforming growth factor beta receptor type I, II, and III during liver regeneration Am J Surg 169 1995 126 131
90. L.G. Gomella E.R. Sargent W.M. Linehan A. Kasid Transforming growth factor-beta inhibits the growth of renal cell carcinoma in vitro J Urol 141 1989 1240 1244
91. R. Erlandsson F. Boldog B. Persson E.R. Zabarovsky R.L. Allikmets J. Sümegi G. Klein H. Jörnvall The gene from the short arm of chromosome 3, at D3F15S2, frequently deleted in renal cell carcinoma, encodes acylpeptide hydrolase Oncogene 6 1991 1293 1295
92. F. Boldog K. Arheden S. Imreh B. Strömbeck L. Szekely R. Erlandsson Z. Marcsek J. Sümegi F. Mitelman G. Klein Involvement of 3p deletions in sporadic and hereditary forms of renal cell carcinoma Genes Chromosom Cancer 3 1991 403 406
93. S. Tsunasawa K. Narita K. Ogata Purification and properties of acylamino acid releasing enzyme from rat liver J Biochem (Tokyo) 77 1975 89 102
94. W. Gade J.L. Brown Purification and partial characterization of alpha-N-acylpeptide hydrolase from bovine liver J Biol Chem 253 1978 5012 5018
95. W.M. Jones J.M. Manning Acylpeptide hydrolase activity from erythrocytes Biochem Biophys Res Commun 126 1985 933 940
96. K. Kobayashi L.W. Lin J.E. Yeadon L.B. Klickstein J.A. Smith Cloning and sequence analysis of a rat liver cDNA encoding acyl-peptide hydrolase J Biol Chem 264 1989 8892 8899
97. L.H. Klotz C. Kulkarni G. Mills End stage renal disease serum contains a specific renal cell growth factor J Urol 145 1991 156 160
98. A. Scaloni W. Jones M. Pospischil S. Sassa O. Schneewind A.M. Popowicz F. Bossa S.L. Graziano J.M. Manning Deficiency of acylpeptide hydrolase in small-cell lung carcinoma cell lines J Lab Clin Med 120 1992 546 552
99. A. Lindblom P. Tannergård B. Werelius M. Nordenskjöld Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer Nat Genet 5 1993 279 282
100. N. Papadopoulos N.C. Nicolaides Y.F. Wei S.M. Ruben K.C. Carter C.A. Rosen W.A. Haseltine R.D. Fleischmann C.M. Fraser M.D. Adams J.C. Venter S.R. Hamilton G.M. Petersen P. Watson H.T. Lynch P. Peltomäki J.-P. Mecklin A. de la Chapelle Mutation of a mutL homolog in hereditary colon cancer Science 263 1994 1625 1629
101. R.D. Kolodner N.R. Hall J. Lipford M.F. Kane P.T. Morrison P.J. Finan J. Burn P. Chapman C. Earabino E. Merchant T.D. Bishop Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1 mutations Cancer Res 55 1995 242 248
102. H.-J. Han M. Maruyama S. Baba J.-G. Park Y. Nakamura Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (Hnpcc) Hum Mol Genet 4 1995 237 242
103. P. Peltomäki R.A. Lothe L.A. Aaltonen L. Pylkkänen M. Nyström-Lahti R. Seruca L. David R. Holm D. Ryberg A. Haugen Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome Cancer Res 53 1993 5853 5855
104. C.M. Wilke S.W. Guo B.K. Hall F. Boldog R.M. Gemmill S.C. Chandrasekharappa C.L. Barcroft H.A. Drabkin T.W. Glover Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the t(3;8) associated with hereditary renal cell carcinoma Genomics 22 1994 319 326
105. F.L. Boldog B. Waggoner T.W. Glover I. Chumakov D. Le Paslier D. Cohen R.M. Gemmill H.A. Drabkin Integrated YAC contig containing the 3p14.2 hereditary renal carcinoma 3;8 translocation breakpoint and the fragile site FRA3B Genes Chromosom Cancer 11 1994 216 221
106. M. Ohta H. Inoue M.G. Cotticelli K. Kastury R. Baffa J. Palazzo Z. Siprashvili M. Mori P. McCue T. Druck C.M. Croche K. Hueber The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers Cell 84 1996 587 597
107. L. Virgilio M. Shuster S.M. Gollin M.L. Veronese M. Ohta K. Huebner C.M. Croce FHIT gene alterations in head and neck squamous cell carcinomas Proc Natl Acad Sci USA 93 1996 9770 9775
108. M. Negrini C. Monaco I. Vorechovsky M. Ohta T. Druck R. Baffa K. Huebner C.M. Croce The FHIT gene at 3p14.2 is abnormal in breast carcinomas Cancer Res 56 1996 3173 3179
109. G. Sozzi H. Alder S. Tornielli V. Corletto R. Baffa M.L. Veronese M. Negrini S. Pilotti M.A. Pierotti K. Huebner C.M. Croce Aberrant FHIT transcripts in Merkel cell carcinoma Cancer Res 56 1996 2472 2474
110. G. Sozzi M.L. Veronese M. Negrini R. Baffa M.G. Cotticelli H. Inoue S. Tornielli S. Pilotti L. De Gregorio U. Pastorino M.A. Pierotti M. Ohta K. Huebner C.M. Croce The FHIT gene 3p14.2 is abnormal in lung cancer Cell 85 1996 17 26
111. S. Thiagalingam N.A. Lisitsyn M. Hamaguchi M.H. Wigler J.K. Willson S.D. Markowitz F.S. Leach K.W. Kinzler B. Vogelstein Evaluation of the FHIT gene in colorectal cancers Cancer Res 56 1996 2936 2939
112. S. LaForgia B. Morse J. Levy G. Barnea L.A. Cannizzaro F. Li P.C. Nowell L. Boghosian-Sell J. Glick A. Weston C.C. Harris H. Drabkin D. Patterson C.M. Corce J. Schlessinger K. Huebner Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21 Proc Natl Acad Sci USA 88 1991 5036 5050
113. T. Hunter Protein-tyrosine phosphatases the other side of the coin Cell 58 1989 1013 1016
114. T. Tsukamoto T. Takahashi R. Ueda K. Hibi H. Saito T. Takahashi Molecular analysis of the protein tyrosine phosphatase gamma gene in human lung cancer cell lines Cancer Res 52 1992 3506 3509
115. G. Barnea O. Silvennoinen B. Shaanan A.M. Honegger P.D. Canoll P. D’Eustachio B. Morse J.B. Levy S. Laforgia K. Huebner Identification of a carbonic anhydrase-like domain in the extracellular region of RPTP gamma defines a new subfamily of receptor tyrosine phosphatases Mol Cell Biol 13 1993 1497 1506
116. K.K. Wary Z. Lou A.M. Buchberg L.D. Siracusa T. Druck S. LaForgia K. Huebner A homozygous deletion within the carbonic anhydrase-like domain of the PTPRG gene in murine L-cells Cancer Res 53 1993 1498 1502
117. J. Groden A. Thliveris W. Samowitz M. Carlson L. Gelbert H. Albertsen G. Joslyn J. Stevens L. Spirio M. Robertson L. Sargeant K. Krapcho E. Wolff R. Burt J.P. Hughes J. Warrington J. McPherson J. Wasmuth D. le Paslier H. Abderrahim Identification and characterization of the familial adenomatous polyposis coli gene Cell 66 1991 589 600
118. J.C. Barber K.H. Ellis L.V. Bowles J.D. Delhanty R.F. Ede B.M. Male D.M. Eccles Adenomatous polyposis coli and a cytogenetic deletion of chromosome 5 resulting from a maternal intrachromosomal insertion J Med Genet 31 1994 312 316
119. K.J. Smith K.A. Johnson T.M. Bryan D.E. Hill S. Markowitz J.K. Willson C. Paraskeva G.M. Petersen S.R. Hamilton B. Vogelstein K.W. Kinzler The APC gene product in normal and tumor cells Proc Natl Acad Sci USA 90 1993 2846 2850
120. L.-K. Su B. Vogelstein K.W. Kinzler Association of the APC tumor suppressor protein with catenins Science 262 1993 1734 1737
121. S.M. Powell N. Zilz Y. Beazer-Barclay T.M. Bryan S.R. Hamilton S.N. Thibodeau B. Vogelstein K.W. Kinzler APC mutations occur early during colorectal tumorigenesis Nature 359 1992 235 237
122. G. Tamura C. Maesawa Y. Suzuki S. Ogasawara M. Terashima K. Saito R. Satodate Primary gastric carcinoma cells frequently lose heterozygosity at the APC and MCC genetic loci Jpn J Cancer Res 84 1993 1015 1018
123. M. Okamoto M. Sasaki K. Sugio C. Sato T. Iwama T. Ikeuchi A. Tonomura T. Sasazuki M. Miyaki Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli Nature 331 1988 273 277
124. E. Solomon R. Voss V. Hall W.F. Bodmer J.R. Jass A.J. Jeffreys F.C. Lucibello I. Patel S.H. Rider Chromosome 5 allele loss in human colorectal carcinomas Nature 328 1987 616 619
125. B. Vogelstein E.R. Fearon S.R. Hamilton S.E. Kern A.C. Preisinger M. Leppert Y. Nakamura R. White A.M.M. Smith J.L. Bos Genetic alterations during colorectal tumor development N Engl J Med 319 1988 525 532
126. L.-K. Su K.A. Johnson K.J. Smith D.E. Hill B. Vogelstein K.W. Kinzler Association between wild type and mutant APC gene products Cancer Res 53 1993 2728 2731
127. M. Oshima H. Oshima K. Kitagawa M. Kobayashi C. Itakura M. Taketo Loss of APC heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene Proc Natl Acad Sci USA 92 1995 4482 4486
128. K.W. Kinzler M.C. Nilbert B. Vogelstein T.M. Bryan D.B. Levy K.J. Smith A.C. Preisinger S.R. Hamilton P. Hedge A. Markham M. Carlson G. Joslyn J. Groden R. White Y. Miki Y. Miyoshi I. Nishisho Y. Nakamura Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers Science 251 1991 1366 1370
129. K.W. Ah-See T.G. Cooke I.R. Pickford D. Soutar A. Balmain An allelotype of squamous carcinoma of the head and neck using microsatellite markers Cancer Res 54 1994 1617 1621
130. M. Serrano G.J. Hannon D. Beach A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Nature 366 1993 704 707
131. J. Lukas D. Parry L. Aagaard D.J. Mann J. Bartkova M. Strauss G. Peters J. Bartek Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 Nature 375 1995 503 506
132. C. Caldas S.A. Hahn L.T. da Costa M.S. Redston M. Schutte A.B. Seymour C.L. Weinstein R.H. Hruban C.J. Yeo Frequent somatic mutations and homozygous deletions of the p16 (Mts1) gene in pancreatic adenocarcinoma Nat Genet 8 1994 27 32
133. J. Hebert J.M. Cayuela J. Berkeley F. Sigaux Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias Blood 84 1994 4038 4044
134. O. Washimi M. Nagatake H. Osada R. Ueda T. Koshikawa T. Seki T. Takahashi In vivo occurrence of p16 (Mts1) and p15 (Mts2) alterations preferentially in non-small cell lung cancers Cancer Res 55 1995 514 517
135. A. Kamb N.A. Gruis J. Weaver-Feldhaus Q. Liu K. Harshman S.V. Tavtigian E. Stockert R.S. Day III B.E. Johnson M.H. Skolnick A cell cycle regulator potentially involved in genesis of many tumor types Science 264 1994 436 440
136. N.A. Gruis P.A. van der Velden L.A. Sandkuijl D.E. Prins J. Weaver-Feldhaus A. Kamb W. Bergman R. Frants Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds Nat Genet 10 1995 351 353
137. G.J. Hannon D. Beach p15(Ink4b) is a potential effector of TGF-beta-induced cell cycle arrest Nature 371 1994 257 261
138. B.A. Wallace R.C. Nairn Renal tubular antigens in kidney tumors Cancer 29 1972 977 981
139. A. Nordenskjöld Molecular studies on Wilms’ tumor and genetical malformations 1995 Doctoral dissertation Karolinska Institutet, Stockholm
140. S.L. Madden D.M. Cook J.F. Morris A. Gashler V.P. Sukhatme F.J. Rauscher III Transcriptional repression mediated by the WR1 Wilms tumor gene products Science 253 1991 1550 1553
141. G.R. Dressler Transcription factors in renal development the WT1 and Pax-2 story Semin Nephrol 15 1995 263 271
142. G. Ryan V. Steele-Perkins J.F. Morris F.J. Rauscher III G.R. Dressler Repression of Pax-2 by WT1 during normal kidney development Development 121 1995 867 875
143. R. Wooster S.L. Neuhausen J. Mangion Y. Quirk D. Ford N. Collins K. Nguyen S. Seal T. Tran D. Averill P. Fields G. Marshall S. Narod G.M. Lenoir H. Lynch J. Feunteun P. Devilee C.J. Cornelisse F.H. Menko P.A. Daly W. Ormiston Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13 Science 265 1994 2088 2090
144. M. Schutte L.T. da Costa S.A. Hahn C. Moskaluk A.T.M.S. Hoque E. Rozenblum C.L. Weinstein M. Bittner P.S. Meltzer J.M. Trent C.J. Yeo R.H. Hruban S.E. Kern Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies with the BRCA2 region Proc Natl Acad Sci USA 92 1995 5950 5954
145. T. Kouzarides Transcriptional control by the retinoblastoma protein Semin Cancer Biol 6 1995 91 98
146. L. Szekely Involvement of retinoblastoma and p53 tumor suppressor proteins in cell differentiation and Epstein-Barr virus–mediated B-cell transformation 1995 Doctoral dissertation Karolinska Institutet, Stockholm
147. J.M. Dunn R.A. Phillips X. Zhu A. Becker B.L. Gallie Mutations in the RB1 gene and their effects on transcription Mol Cell Biol 9 1989 4596 4604
148. J.M. Horowitz S.H. Park D.W. Yandell R.A. Weinberg Involvement of the retinoblastoma gene in the genesis of various human tumors W. Kavenee N. Hastie E. Stanbridge Recessive Oncogenes and Tumor Suppression current Communications in Molecular Biology 1989 Cold Spring Harbor Laboratory Press New York 101 108
149. F.L. Munier M.X. Wang M.A. Spence F. Thonney A. Balmer G. Pescia L.A. Donoso A.L. Murphree Pseudo low penetrance in retinoblastoma fortuitous familial aggregation of sporadic cases caused by independently derived mutations in two large pedigrees Arch Ophthalmol 111 1993 1507 1511
150. C.H. Hensel C.L. Hsieh A.F. Gazdar B.E. Johnson A.Y. Sakaguchi S.L. Naylor W.H. Lee E.Y. Lee Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer Cancer Res 50 1990 3067 3072
151. J. Yokota T. Akiyama Y. Fung W. Benedict Y. Namba M. Hanaoka M. Wada T. Terasaki Y. Shimosato T. Sugimura M. Terada Altered expression of the retinoblastoma (Rb) gene in small cell carcinoma of the lung Oncogene 3 1988 471 475
152. J.W. Harbour S.L. Lai J. Whang-Peng A.F. Gazdar J.D. Minna F.J. Kaye Abnormalities in structure and expression of the human retinoblastoma gene in SCLC Science 241 1988 353 357
153. V.L. Cryns A. Thor H.J. Xu S.X. Hu M.E. Wierman A.L. Vickery Jr W.F. Benedict A. Arnold Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma N Engl J Med 330 1994 757 761
154. D.J. Venter K.L. Bevan R.L. Ludwig T.E. Riley P.S. Jat D.G. Thomas M.D. Noble Retinoblastoma gene deletions in human glioblastomas Oncogene 6 1991 445 448
155. R. Bookstein P. Rio S.A. Madreperla F. Hong C. Allred W.E. Grizzle W.H. Lee Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma Proc Natl Acad Sci USA 87 1990 7762 7766
156. A. T’Ang J.M. Varley S. Chakraborty A.L. Murphree Y.K.T. Fung Structural rearrangement of the retinoblastoma gene in human breast carcinoma Science 242 1988 263 266
157. Y. Liu M. Heyman Y. Wang U. Falkmer C. Hising L. Szekely S. Einhorn Molecular analysis of the retinoblastoma gene in primary ovarian cancer cells Int J Cancer 58 1994 663 667
158. D.W. Goodrich Y. Chen P. Scully W.H. Lee Expression of the retinoblastoma gene product in bladder carcinoma cells associates with a low frequency of tumor formation Cancer Res 52 1992 1968 1973
159. A.A. Ali J.N. Marcus J.P. Harvey R. Roll C.P. Hodgson D.M. Wildrick A. Chakraborty B.M. Boman RB1 protein in normal and malignant human colorectal tissue and colon cancer cell lines FASEB J 7 1993 931 937
160. J.D. Brooks G.S. Bova F.F. Marshall W.B. Isaacs Tumor suppressor gene allelic loss in human renal cancers J Urol 150 1993 1278 1283
161. H.J. Decker B. Wullich J.M. Whaley G. Herrera S.M. Klauck A.A. Sandberg D.W. Yandell B.R. Seizinger Cytogenetic and molecular studies of a familial renal cell carcinoma Cancer Genet Cytogenet 63 1992 25 31
162. J. Ishikawa H.-J. Xu S.-X. Hu D.W. Yandell S. Maeda S. Kamidono W.F. Benedict R. Takahashi Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas Cancer Res 51 1991 5736 5743
163. S. Torigoe T. Shuin Y. Kubota T. Horikoshi K. Danenberg P.V. Danenberg p53 gene mutation in primary human renal cell carcinoma Oncol Res 4 1992 467 472
164. Y. Suzuki G. Tamura Mutations of the p53 gene in carcinomas of the urinary system Acta Pathol Jpn 43 1993 745 750
165. F.J. Bot J.C. Godschalk K.K. Krishnadath T.H. van der Kwast F.T. Bosman Prognostic factors in renal-cell carcinoma immunohistochemical detection of p53 protein versus clinicopathological parameters Int J Cancer 57 1994 634 637
166. D. Barker E. Wright K. Nguyen L. Cannon P. Fain D. Goldgar D.T. Bishop J. Carey B. Baty J. Kivlin H. Willard J.S. Wayes G. Greig L. Leinwand Y. Nakamura P. O’Connell M. Leppert J.-M. Lalovel R. White M. Skolnick Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17 Science 236 1987 1100 1102
167. M.R. Wallace D.A. Marchuk L.B. Andersen R. Letcher H.M. Odeh A.M. Saulino J.W. Fountain A. Brereton J. Nicholson A.L. Mitchell B.H. Brownstein F.S. Collins Type 1 neurofibromatosis gene identification of a large transcript disrupted in three NF1 patients Science 249 1990 181 186
168. F. McCormick Ras signaling and NF1 Curr Opin Genet Dev 5 1995 51 55
169. J.E. DeClue A.G. Papageorge J.A. Fletcher S.R. Diehl N. Ratner W.C. Vass D.R. Lowy Abnormal regulation of mammalian p21(ras) contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis Cell 69 1992 265 273
170. D.H. Gutmann R.T. Geist K. Rose G. Wallin J.F. Moley Loss of neurofibromatosis type 1 (Nf1) gene expression in pheochromocytomas from patients without NF1 Genes Chromosom Cancer 13 1995 104 109
171. Y. Li G. Bollag R. Clark J. Stevens L. Conroy D. Fults K. Ward E. Friedman W. Samowitz M. Robertson P. Bradley F. McCormick R. White R. Cawthon Somatic mutations in the neurofibromatosis 1 gene in human tumors Cell 69 1992 275 281
172. R.A. Heim L.M. Silverman R.A. Farber L.N.W. Kam-Morgan Screening for truncated NF1 proteins Nat Genet 8 1994 218 219
173. C.F. Rochlitz S. Peter G. Willroth E. de Kant H. Lobeck D. Huhn R. Herrmann Mutations in the ras protooncogenes are rare events in renal cell cancer Eur J Cancer 28 1992 333 336
174. Y. Miki J. Swensen D. Shattuck-Eidens P.A. Futreal K. Harshman S. Tavtigian Q. Liu C. Cochran L.M. Bennett W. Ding R. Bell J. Rosenthal C. Hussey T. Tran M. McClure C. Frye T. Hattier R. Phelps A. Haugen-Strano H. Katcher K. Yakumo A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
175. Y. Chen C.-F. Chen D.J. Riley D.C. Allred P.-L. Chen D. von Hoff C.K. Osborne W.-H. Lee Aberrant subcellular localization of BRCA1 in breast cancer Science 270 1995 789 791
176. S.D. Merajver T.M. Pham R.F. Caduff M. Chen E.L. Poy K.A. Cooney B.L. Weber F.S. Collins C. Johnston T.S. Frank Somatic mutations in the BRCA1 gene in sporadic ovarian tumours Nat Genet 9 1995 439 443
177. M.E. Thompson R.A. Jensen P.S. Obermiller D.L. Page J.T. Holt Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression Nat Genet 9 1995 444 450
178. L. Hedrick K.R. Cho E.R. Fearon T.C. Wu K.W. Kinzler B. Vogelstein The DCC gene product in cellular differentiation and colorectal tumorigenesis Genes Dev 8 1994 1174 1183
179. W.E. Pierceall M.A. Reale A.F. Candia C.V. Wright K.R. Cho E.R. Fearon Expression of a homologue of the deleted in colorectal cancer (Dcc) gene in the nervous system of developing Xenopus embryos Dev Biol 166 1994 654 665
180. W.E. Pierceall K.R. Cho R.H. Getzenberg M.A. Reale L. Hedrick B. Vogelstein E.R. Fearon NIH3T3 cells expressing the deleted in colorectal cancer tumor suppressor gene product stimulate neurite outgrowth in rat PC12 pheochromocytoma cells J Cell Biol 124 1994 1017 1027
181. R. Narayanan K.G. Lawlor R.Q. Schaapveld K.R. Cho B. Vogelstein P. Bui-Vinh Tran M.P. Osborne N.T. Telang Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts Oncogene 7 1992 553 561
182. A.J. Klingelhutz L. Hedrick K.R. Cho J.K. McDougall The DCC gene suppresses the malignant phenotype of transformed human epithelial cells Oncogene 10 1995 1581 1586
183. S. Miyake K. Nagai K. Yoshino M. Oto M. Endo Y. Yuasa Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis Cancer Res 54 1994 3007 3010
184. M. Kashiwaba G. Tamura M. Ishida Frequent loss of heterozygostiy at the deleted in colorectal carcinoma gene locus and its association with histologic phenotypes in breast carcinoma Virchows Arch 426 1995 441 446
185. G.A. Rouleau W. Wertelecki J.L. Haines W.J. Hobbs J.A. Trofatter B.R. Seizinger R.L. Martuza D.W. Superneau P.M. Conneally J.F. Gusella Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22 Nature 329 1987 246 248
186. J.P. Dumanski E. Carlbom V.P. Collins M. Nordenskjöld Deletion mapping of a locus on human chromosome 22 involved in the genesis of meningioma Proc Natl Acad Sci USA 84 1987 9275 9279
187. G.A. Rouleau P. Merel M. Lutchman M. Sanson J. Zucman C. Marineau K. Hoang-Xuan S. Demczuk C. Desmaze B. Plougastel S.M. Pulst G. Lenoir E. Bijlsma R. Fashold J. Dumanski P. de Jong D. Parry R. Eldridge A. Aurias O. Delattre G. Thomas Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2 Nature 363 1993 515 521
188. J.A. Trofatter M.M. MacCollin J.L. Rutter J.R. Murrell M.P. Duyao D.M. Parry R. Eldridge N. Kley A.G. Menon K. Pulaski V.H. Haase C.M. Ambrose D. Munroe C. Bove J.L. Haines R.L. Martuza M.E. MacDonald B.R. Seizinger M. Short A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor Cell 72 1993 791 800
189. M.H. Ruttledge M.H. Sarrazin S. Rangaratnam C.M. Phelan E. Twist P. Merel O. Delattre G. Thomas M. Nordenskjöld V.P. Collins J.P. Dumanski G.A. Rouleau Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas Nat Genet 6 1994 180 184
190. Murphy WM, Beckwith JB, Farrow GM (1994): Renal cell carcinoma. In: Atlas of Tumor Pathology: Tumors of the Kidney, Bladder and Related Urinary Structures. Armed Forces Institute of Pathology, eds. Armed Forces Institute of Pathology, Washington, pp. 92–131.